Background and Objectives Sarcopenia, which is subclinical loss of skeletal muscle mass, is
commonly observed in patients with malignancy. The objective of this study is to determine …

Background Sarcopenia and post‐operative accelerated muscle loss leading to cachexia
are commonly observed in patients with pancreatic cancer. This study aimed to assess the …

Introduction Assessing patient-specific risk factors for long-term mortality following resection
of pancreatic adenocarcinoma can be difficult. Sarcopenia—the measurement of muscle …

Background While sarcopenia is typically defined using total psoas area (TPA),
characterizing sarcopenia using only a single axial cross-sectional image may be …

Background & aims Recent studies report that muscle depletion can impair short and long-
term results after abdominal surgery. The aim of the present study is to quantify sarcopenia …

Objectives To analyze the effect of preoperative body composition on survival in patients
with pancreatic cancer following pancreaticoduodenectomy (PD). Methods Between October …

Background Skeletal muscle depletion, referred to as sarcopenia, is predictive of mortality in
patients undergoing digestive operations. The impact of muscle quality on outcomes …

Sarcopenia is found in up to 65% of pancreatic cancer patients. The definition and
diagnostic methods for sarcopenia have changed over the years, and the measurement of …

Background Numerous studies have suggested an association between sarcopenia in
pancreatic cancer and adverse outcomes. This systematic review examines the evidence for …

Purpose Surgical resection for gastric adenocarcinoma is associated with significant post-
operative morbidity and mortality. The aim of this study was to assess the prognostic …